Inflammation, C-reactive protein, and atherothrombosis (Q37232611)

19 August 2017

1 reference

title

Inflammation, C-reactive protein, and atherothrombosis (English)

1 reference

19 August 2017

0 references

1

Paul M Ridker

1 reference

19 August 2017

Josh D Silvertown

2

1 reference

PubMed ID

18673009

19 August 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

Journal of Periodontology

19 August 2017

1 reference

19 August 2017

79

1 reference

19 August 2017

1544-1551

1 reference

19 August 2017

8 Suppl

1 reference

The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis

19 August 2017

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

The Contribution of Interleukin‐1 and Tumor Necrosis Factor to Periodontal Tissue Destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Soluble CD40L and cardiovascular risk in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-reactive protein and the future risk of thromboembolic stroke in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Inflammatory markers and the risk of coronary heart disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

A single bolus infusion of C-reactive protein increases gluconeogenesis and plasma glucose concentration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Association of common CRP gene variants with CRP levels and cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Targeting C-reactive protein for the treatment of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

C-Reactive Protein and Cerebral Small-Vessel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2008.080249

21 January 2018

Identifiers

DOI

10.1902/JOP.2008.080249

1 reference

19 August 2017

1 reference

PubMed ID

18673009